CollPlant announces $2.0 million registered direct offering

CollPlant Biotechnologies (NASDAQ: CLGN) has entered into a definitive agreement to sell 1.6 million ordinary shares at $1.25 per share in a registered direct offering expected to generate approximately $2.0 million in gross proceeds before fees and expenses.

The Israel-based regenerative medicine company will also issue warrants in a concurrent private placement. Investors will receive series A warrants to purchase up to 1.6 million ordinary shares and series B warrants to purchase up to 1.6 million ordinary shares, both with an exercise price of $1.25 per share.

The series A warrants will be exercisable immediately and expire five years after the effective date of a registration statement for the underlying shares. The series B warrants will also be exercisable immediately but expire eighteen months after the registration statement becomes effective.

H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering, which is expected to close on or about February 6, 2026, subject to customary closing conditions.

CollPlant stated it intends to use the net proceeds for general corporate purposes, including working capital and funding research and development programs. The company develops products based on its recombinant human collagen technology for tissue regeneration and medical aesthetics applications.

The ordinary shares are being offered under a shelf registration statement filed with the Securities and Exchange Commission in January 2026. The warrants and underlying shares from the private placement have not been registered under federal securities laws.

CollPlant has a development and commercialization agreement with Allergan, an AbbVie company, for dermal and soft tissue fillers that was established in 2021.

You May Also Be Interested In

• Amtech Systems closes $60 million public stock offering
• Hitek Global completes $8 million registered direct offering
• SINTX Technologies raises $5 million through private placement